Drug Testing Integrity Act of 2005
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Drug Testing Integrity Act of 2005 - Declares it is unlawful to: (1) knowingly manufacture, market, sell, ship, or otherwise provide to another individual any product with the intent to assist the use of such product to defraud a drug test (that is, to submit a substance that purports to be from an individual other than its actual source, or purports to have been excreted or collected other than when it was actually excreted or collected); or (2) engage in any other conduct with the intent to produce a false or misleading outcome of a test for the presence of a controlled substance.
Grants the Federal Trade Commission enforcement powers as a violation of an unfair or deceptive act or practice.
Referred to the Subcommittee on Commerce, Trade and Consumer Protection.
- Introduced in House Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). H.R. 2802: Drug Testing Integrity Act of 2005. 109th Congress. Open America. https://openamerica.io/bill/109-HR-2802/
"H.R. 2802: Drug Testing Integrity Act of 2005." 109th Congress, 2026, Open America, https://openamerica.io/bill/109-HR-2802/.
H.R. 2802, 109th Cong. (2026), https://openamerica.io/bill/109-HR-2802/.
[H.R. 2802: Drug Testing Integrity Act of 2005](https://openamerica.io/bill/109-HR-2802/)